Renin-Inhibitors Market Report – Research, Industry Analysis Reports and Market Demands

Global Renin-Inhibitors Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Renin-Inhibitors Introduction
1.2 Market Analysis by Type
- 1.2.1 150mg/Tablet
- 1.2.2 300mg/Tablet
1.3 Market Analysis by Applications
- 1.3.1 Age below 45
- 1.3.2 Age 45-55
- 1.3.3 Age 55-65
- 1.3.4 Age above 65
1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
  - 1.4.1.1 United States Market States and Outlook (2014-2024)
  - 1.4.1.2 Canada Market States and Outlook (2014-2024)
  - 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  - 1.4.2.1 Germany Market States and Outlook (2014-2024)
  - 1.4.2.2 France Market States and Outlook (2014-2024)
  - 1.4.2.3 UK Market States and Outlook (2014-2024)
  - 1.4.2.4 Russia Market States and Outlook (2014-2024)
  - 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  - 1.4.3.1 China Market States and Outlook (2014-2024)
  - 1.4.3.2 Japan Market States and Outlook (2014-2024)
  - 1.4.3.3 Korea Market States and Outlook (2014-2024)
  - 1.4.3.4 India Market States and Outlook (2014-2024)
  - 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
  - 1.4.4.1 Brazil Market States and Outlook (2014-2024)
  - 1.4.4.2 Egypt Market States and Outlook (2014-2024)
  - 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
  - 1.4.4.4 South Africa Market States and Outlook (2014-2024)
  - 1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Novartis
- 2.1.1 Business Overview
- 2.1.2 Renin-Inhibitors Type and Applications
  - 2.1.2.1 Product A
  - 2.1.2.2 Product B
- 2.1.3 Novartis Renin-Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Noden Pharma
- 2.2.1 Business Overview
- 2.2.2 Renin-Inhibitors Type and Applications
  - 2.2.2.1 Product A
  - 2.2.2.2 Product B
- 2.2.3 Noden Pharma Renin-Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Renin-Inhibitors Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Renin-Inhibitors Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Renin-Inhibitors Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
- 3.3.1 Top 3 Renin-Inhibitors Manufacturer Market Share in 2018
- 3.3.2 Top 6 Renin-Inhibitors Manufacturer Market Share in 2018
3.4 Market Competition Trend

4 Global Renin-Inhibitors Market Analysis by Regions

4.1 Global Renin-Inhibitors Sales, Revenue and Market Share by Regions
- 4.1.1 Global Renin-Inhibitors Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Renin-Inhibitors Revenue and Market Share by Regions (2014-2019)
4.2 North America Renin-Inhibitors Sales and Growth Rate (2014-2019)
4.3 Europe Renin-Inhibitors Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Renin-Inhibitors Sales and Growth Rate (2014-2019)
4.5 South America Renin-Inhibitors Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Renin-Inhibitors Sales and Growth Rate (2014-2019)

5 North America Renin-Inhibitors by Country

5.1 North America Renin-Inhibitors Sales, Revenue and Market Share by Country
- 5.1.1 North America Renin-Inhibitors Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Renin-Inhibitors Revenue and Market Share by Country (2014-2019)
5.2 United States Renin-Inhibitors Sales and Growth Rate (2014-2019)
5.3 Canada Renin-Inhibitors Sales and Growth Rate (2014-2019)
5.4 Mexico Renin-Inhibitors Sales and Growth Rate (2014-2019)

6 Europe Renin-Inhibitors by Country

6.1 Europe Renin-Inhibitors Sales, Revenue and Market Share by Country
- 6.1.1 Europe Renin-Inhibitors Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Renin-Inhibitors Revenue and Market Share by Country (2014-2019)
6.2 Germany Renin-Inhibitors Sales and Growth Rate (2014-2019)
6.3 UK Renin-Inhibitors Sales and Growth Rate (2014-2019)
6.4 France Renin-Inhibitors Sales and Growth Rate (2014-2019)
6.5 Russia Renin-Inhibitors Sales and Growth Rate (2014-2019)
6.6 Italy Renin-Inhibitors Sales and Growth Rate (2014-2019)

7 Asia-Pacific Renin-Inhibitors by Country

7.1 Asia-Pacific Renin-Inhibitors Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Renin-Inhibitors Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Renin-Inhibitors Revenue and Market Share by Country (2014-2019)
7.2 China Renin-Inhibitors Sales and Growth Rate (2014-2019)
7.3 Japan Renin-Inhibitors Sales and Growth Rate (2014-2019)
7.4 Korea Renin-Inhibitors Sales and Growth Rate (2014-2019)
7.5 India Renin-Inhibitors Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Renin-Inhibitors Sales and Growth Rate (2014-2019)

8 South America Renin-Inhibitors by Country

8.1 South America Renin-Inhibitors Sales, Revenue and Market Share by Country
- 8.1.1 South America Renin-Inhibitors Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Renin-Inhibitors Revenue and Market Share by Country (2014-2019)
8.2 Brazil Renin-Inhibitors Sales and Growth Rate (2014-2019)
8.3 Argentina Renin-Inhibitors Sales and Growth Rate (2014-2019)
8.4 Colombia Renin-Inhibitors Sales and Growth Rate (2014-2019)

9 Middle East and Africa Renin-Inhibitors by Countries

9.1 Middle East and Africa Renin-Inhibitors Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Renin-Inhibitors Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Renin-Inhibitors Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Renin-Inhibitors Sales and Growth Rate (2014-2019)
9.3 Turkey Renin-Inhibitors Sales and Growth Rate (2014-2019)
9.4 Egypt Renin-Inhibitors Sales and Growth Rate (2014-2019)
9.5 Nigeria Renin-Inhibitors Sales and Growth Rate (2014-2019)
9.6 South Africa Renin-Inhibitors Sales and Growth Rate (2014-2019)

10 Global Renin-Inhibitors Market Segment by Type

10.1 Global Renin-Inhibitors Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Renin-Inhibitors Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Renin-Inhibitors Revenue and Market Share by Type (2014-2019)
10.2 150mg/Tablet Sales Growth and Price
- 10.2.1 Global 150mg/Tablet Sales Growth (2014-2019)
- 10.2.2 Global 150mg/Tablet Price (2014-2019)
10.3 300mg/Tablet Sales Growth and Price
- 10.3.1 Global 300mg/Tablet Sales Growth (2014-2019)
- 10.3.2 Global 300mg/Tablet Price (2014-2019)

11 Global Renin-Inhibitors Market Segment by Application

11.1 Global Renin-Inhibitors Sales Market Share by Application (2014-2019)
11.2 Age below 45 Sales Growth (2014-2019)
11.3 Age 45-55 Sales Growth (2014-2019)
11.4 Age 55-65 Sales Growth (2014-2019)
11.5 Age above 65 Sales Growth (2014-2019)

12 Renin-Inhibitors Market Forecast (2019-2024)

12.1 Global Renin-Inhibitors Sales, Revenue and Growth Rate (2019-2024)
12.2 Renin-Inhibitors Market Forecast by Regions (2019-2024)
- 12.2.1 North America Renin-Inhibitors Market Forecast (2019-2024)
- 12.2.2 Europe Renin-Inhibitors Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Renin-Inhibitors Market Forecast (2019-2024)
- 12.2.4 South America Renin-Inhibitors Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Renin-Inhibitors Market Forecast (2019-2024)
12.3 Renin-Inhibitors Market Forecast by Type (2019-2024)
- 12.3.1 Global Renin-Inhibitors Sales Forecast by Type (2019-2024)
- 12.3.2 Global Renin-Inhibitors Market Share Forecast by Type (2019-2024)
12.4 Renin-Inhibitors Market Forecast by Application (2019-2024)
- 12.4.1 Global Renin-Inhibitors Sales Forecast by Application (2019-2024)
- 12.4.2 Global Renin-Inhibitors Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

Description

Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.

Scope of the Report:
USA is still the largest consumption region of Tekturna, occupied about 56% market share globally, with revenue 39.21 million USD in 2017. At the same time, Asia will see the considerable growth since Noden Pharma DAC had successfully entered into an agreement with Orphan Pacific (Japan) and Lee’s Pharmaceutical Holdings Limited (China).
The worldwide market for Renin-Inhibitors is expected to grow at a CAGR of roughly 5.6% over the next five years, will reach 100 million US$ in 2024, from 69 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Renin-Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Novartis
Noden Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
150mg/Tablet
300mg/Tablet

Market Segment by Applications, can be divided into
Age below 45
Age 45-55
Age 55-65
Age above 65

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Renin-Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Renin-Inhibitors, with price, sales, revenue and global market share of Renin-Inhibitors in 2017 and 2018.
Chapter 3, the Renin-Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Renin-Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Renin-Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Renin-Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.